Iclusig 45MG tablet & iclusig 15MG tablet

Ended Awarded Last action

Contract number
36C26021F0018
Awardee
Awarding agency
Obligated
$126,524

Award facts

Contract value 64% obligated
$197,695.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02139, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$103,520
Original award $230,044

About this award

This federal contract award is for the delivery of ICLUSIG 45MG TABLET and ICLUSIG 15MG TABLET pharmaceuticals to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $197,695.41 contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. Takeda Pharmaceuticals America is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract was awarded as a delivery order against Takeda's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract has a firm fixed price and is not designated as a set-aside. The ICLUSIG products will be delivered to VA medical facilities under the agency's Veterans Integrated Service Network (VISN) 20, which serves the New England region.

Quick answers

Who was awarded contract 36C26021F0018?

36C26021F0018 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2020.

How much is contract 36C26021F0018 worth?

The government has obligated $126,524 on 36C26021F0018. Its current value, with exercised options, is $197,695.

Is contract 36C26021F0018 an order under another contract?

Yes. 36C26021F0018 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26021F0018 competed?

The extent of competition for 36C26021F0018 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award